Quest Diagnostics Inc Slammed After Earnings, Here’s Where It's Going

This morning, leading diagnostic testing stock, Quest Diagnostics Inc (DGX), is getting slammed after issuing guidance. The medical services company is trading lower by more than 5.0% to $148.40 a share. Today, the stock broke below the important 50-day moving average. This puts the stock in a weak technical position in the near term. Quest Diagnostics Inc (GDX) stock has now declined by over $20.00 since the start of the new year and is now trending down. 

The next major support level for Quest Diagnostics Inc (DGX) stock will be around the $140.00 level. This support area is where the stock broke out to the upside in early November 2021. It is also where the 50-week moving average is currently and that should add strength to the support area.

Disclaimer: All comments made by InTheMoneyStocks, LLC and its subsidiaries, instructors, and representatives are for educational and informational purposes only and should not be construed as ...

more
How did you like this article? Let us know so we can better customize your reading experience.

Comments

Leave a comment to automatically be entered into our contest to win a free Echo Show.
Or Sign in with